SE9802538D0 - New pharmaceutically active compounds - Google Patents

New pharmaceutically active compounds

Info

Publication number
SE9802538D0
SE9802538D0 SE9802538A SE9802538A SE9802538D0 SE 9802538 D0 SE9802538 D0 SE 9802538D0 SE 9802538 A SE9802538 A SE 9802538A SE 9802538 A SE9802538 A SE 9802538A SE 9802538 D0 SE9802538 D0 SE 9802538D0
Authority
SE
Sweden
Prior art keywords
active compounds
pharmaceutically active
6alkyl
new pharmaceutically
optionally substituted
Prior art date
Application number
SE9802538A
Other languages
English (en)
Swedish (sv)
Inventor
Kostas Karabelas
Matti Lepistoe
Peter Sjoe
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9802538A priority Critical patent/SE9802538D0/xx
Publication of SE9802538D0 publication Critical patent/SE9802538D0/xx
Priority to AT99933385T priority patent/ATE248163T1/de
Priority to EP99933385A priority patent/EP1095039B1/fr
Priority to DE69910787T priority patent/DE69910787T2/de
Priority to PCT/SE1999/001145 priority patent/WO2000002877A2/fr
Priority to AU49448/99A priority patent/AU4944899A/en
Priority to JP2000559107A priority patent/JP2002531382A/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE9802538A 1998-07-13 1998-07-13 New pharmaceutically active compounds SE9802538D0 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE9802538A SE9802538D0 (sv) 1998-07-13 1998-07-13 New pharmaceutically active compounds
AT99933385T ATE248163T1 (de) 1998-07-13 1999-06-23 Neuartige, pharmazeutisch aktive verbindung
EP99933385A EP1095039B1 (fr) 1998-07-13 1999-06-23 Nouveaux composes pharmaceutiques
DE69910787T DE69910787T2 (de) 1998-07-13 1999-06-23 Neuartige, pharmazeutisch aktive verbindung
PCT/SE1999/001145 WO2000002877A2 (fr) 1998-07-13 1999-06-23 Nouveaux composes pharmaceutiques
AU49448/99A AU4944899A (en) 1998-07-13 1999-06-23 New pharmaceutically active compounds
JP2000559107A JP2002531382A (ja) 1998-07-13 1999-06-23 新たな医薬活性化合物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9802538A SE9802538D0 (sv) 1998-07-13 1998-07-13 New pharmaceutically active compounds

Publications (1)

Publication Number Publication Date
SE9802538D0 true SE9802538D0 (sv) 1998-07-13

Family

ID=20412083

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9802538A SE9802538D0 (sv) 1998-07-13 1998-07-13 New pharmaceutically active compounds

Country Status (7)

Country Link
EP (1) EP1095039B1 (fr)
JP (1) JP2002531382A (fr)
AT (1) ATE248163T1 (fr)
AU (1) AU4944899A (fr)
DE (1) DE69910787T2 (fr)
SE (1) SE9802538D0 (fr)
WO (1) WO2000002877A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030084444A (ko) 2002-04-26 2003-11-01 주식회사 파나진 Ｐｎａ 올리고머를 합성하기 위한 신규한 단량체 및 그의제조방법
KR20070073887A (ko) * 2004-10-12 2007-07-10 그렌마크 파머수티칼스 에스. 아. 신규한 디펩티딜 펩티다제 ⅳ 억제제, 이를 함유하는약제학적 조성물, 및 이의 제조공정
CN101087757B (zh) * 2004-10-12 2013-01-02 格兰马克药品股份有限公司 二肽基肽酶ⅳ抑制剂、含有它们的药用组合物及其制备方法
US9708350B2 (en) 2014-12-04 2017-07-18 Shin-Etsu Chemical Co., Ltd. Method for producing polyalkylene glycol derivative having amino group at end, polymerization initiator for use in the same, and alcohol compound as raw material for the polymerization initiator
JP6460937B2 (ja) * 2014-12-04 2019-01-30 信越化学工業株式会社 末端にアミノ基を有するポリアルキレングリコール誘導体の製造方法
US10377775B2 (en) 2014-12-04 2019-08-13 Shin-Etsu Chemical Co., Ltd. Method for producing polyalkylene glycol derivative having amino group at end

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ227850A (en) * 1988-02-10 1991-11-26 Hoffmann La Roche Indole substituted pyrrole derivatives; preparatory process and medicaments for use against inflammatory immunological, bronchopulmonary or vascular disorders
AR017200A1 (es) * 1997-12-23 2001-08-22 Astrazeneca Ab Compuestos inhibidores de la proteina cinasa c, sales farmaceuticamente aceptables de los mismos, formulaciones farmaceuitcas que los comprenden, usode las mismas y proceso para la sintesis de dichos compuestos

Also Published As

Publication number Publication date
AU4944899A (en) 2000-02-01
WO2000002877A3 (fr) 2000-04-13
JP2002531382A (ja) 2002-09-24
EP1095039B1 (fr) 2003-08-27
ATE248163T1 (de) 2003-09-15
EP1095039A2 (fr) 2001-05-02
WO2000002877A2 (fr) 2000-01-20
DE69910787T2 (de) 2004-07-08
DE69910787D1 (de) 2003-10-02

Similar Documents

Publication Publication Date Title
SE9504661D0 (sv) New compounds
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
NO308794B1 (no) Farmakologisk aktive pyridin-derivater, preparater inneholdende forbindelsene samt forbindelsenes anvendelse
MY119403A (en) Novel compounds with analgesic effect.
RU95101048A (ru) Производные пролинамида, фармкомпозиция на их основе
DK1204654T3 (da) Benzofurylpiperaziner og benzofurylhomopiperaziner: Serotonin agonister
DK0977741T3 (da) Substituerede phenylderivater, deres fremstilling og anvendelse
EA200200208A1 (ru) Синергитическая композиция
EA200000723A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
SE9900961D0 (sv) Novel compounds
DE60121461D1 (de) Kondensierte pyridoindolderivate
SE9802208D0 (sv) Novel compounds
IT1285770B1 (it) Composti corticoidei
MXPA02002452A (es) Agentes preventivos y terapeuticos para enfermedades de oftalmicas.
DE60112960D1 (de) Kondensierte pyridoindolderivate
NZ240481A (en) Aminosulphonyl urea derivatives and pharmaceutical compositions
SE9902267D0 (sv) New compounds
SE9402880D0 (sv) New peptide derivatives
MD502G2 (ro) Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin
BR9813719A (pt) Agentes terapêuticos
SE9902387D0 (sv) New pharmaceutically active compounds
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
SE9802538D0 (sv) New pharmaceutically active compounds